David P. Pauluzzi
Vorstandsvorsitzender bei Pathnostics LLC
Profil
David P.
Pauluzzi is currently the Vice Chairman & Chief Executive Officer at Pathnostics LLC.
Previously, he held positions such as President, Chief Executive Officer & COO at PLUS Diagnostics, Inc. in 2011, Senior Director-World Wide Marketing at Ventana Medical Systems, Inc., and Executive Director & Vice President at Quest Diagnostics, Inc. from 2002 to 2007.
He also worked as a Director at Transgenomic, Inc. from 2008 to 2009 and as an International Marketing Manager at Abbott Laboratories.
Prior to that, he was the Vice President-Sales & Marketing at US Pathology Labs, Inc. from 2000 to 2002 and worked as a Principal at Abbotts Ltd.
Mr. Pauluzzi completed his undergraduate degree at Loyola University of Chicago.
Aktive Positionen von David P. Pauluzzi
Unternehmen | Position | Beginn |
---|---|---|
Pathnostics LLC
Pathnostics LLC Medical/Nursing ServicesHealth Services Pathnostics operates as a diagnostic solutions company. It provides treatment options, including an emphasis on antibiotic stewardship, It helps physicians to champion patient health today and in the future. The company is headquartered in Irvine, CA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David P. Pauluzzi
Unternehmen | Position | Ende |
---|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Direktor/Vorstandsmitglied | 01.01.2009 |
QUEST DIAGNOSTICS INCORPORATED | Direktor/Vorstandsmitglied | 01.01.2007 |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Vertrieb & Marketing | 01.01.2002 |
Abbotts Ltd.
Abbotts Ltd. Real Estate DevelopmentFinance Abbotts Ltd. is a British company that provides real estate services. The private company is based in Clacton On Sea, UK. The CEO of the company is Harry Douglas Hill. | Corporate Officer/Principal | - |
PLUS Diagnostics, Inc.
PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ. | Vorstandsvorsitzender | - |
Ausbildung von David P. Pauluzzi
Loyola University of Chicago | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
QUEST DIAGNOSTICS INCORPORATED | Health Services |
Private Unternehmen | 6 |
---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Services |
PLUS Diagnostics, Inc.
PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services PLUS Diagnostics, Inc. provides comprehensive pathology services. The firm specializes in genitourinary and gastrointestinal pathology, breast pathology, dermatopathology, hematopathology, oral and maxillofacial pathology. The company was founded in 1990 and is headquartered in Union, NJ. | Health Services |
Abbotts Ltd.
Abbotts Ltd. Real Estate DevelopmentFinance Abbotts Ltd. is a British company that provides real estate services. The private company is based in Clacton On Sea, UK. The CEO of the company is Harry Douglas Hill. | Finance |
Pathnostics LLC
Pathnostics LLC Medical/Nursing ServicesHealth Services Pathnostics operates as a diagnostic solutions company. It provides treatment options, including an emphasis on antibiotic stewardship, It helps physicians to champion patient health today and in the future. The company is headquartered in Irvine, CA. | Health Services |